NCT03175133

Brief Summary

This study will pilot a strengthening intervention targeted to muscles found to be important to gait in people with multiple sclerosis (MS). Previous studies that have tried to strengthen leg and trunk muscles in people with MS have failed to improve walking ability consistently. The investigators think that is because strengthening exercises were not targeted to the correct muscle groups. For this study the investigators propose targeting muscle groups that they have found to be strong contributors to walking in a prior study. This is the first study to target these muscles, so the investigators propose doing a small trial to first evaluate the feasibility of the strength program and the outcomes. The investigators will measure strength and walking measures twice before and once after an 8-week strengthening intervention in a single group of 10 people with MS who are able to walk independently. The results of this study will help inform future, larger trials that could change the way strength training is conducted in people with MS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable multiple-sclerosis

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

May 23, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 5, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2017

Completed
Last Updated

April 13, 2018

Status Verified

April 1, 2018

Enrollment Period

6 months

First QC Date

May 23, 2017

Last Update Submit

April 11, 2018

Conditions

Keywords

rehabilitationphysical therapy

Outcome Measures

Primary Outcomes (2)

  • Change in Muscle Strength

    Muscle strength measured by hand-held dynamometry (HHD) and clinical strength tests

    Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up)

  • Change in Timed 25 Foot Walk (T25FW)

    Gait speed over a 25 foot distance

    Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up)

Secondary Outcomes (4)

  • Change in 6-Minute Walk Test

    Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up)

  • Change in Dynamic Gait Index

    Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up)

  • Change in Multiple Sclerosis Walking Scale-12

    Week 0 (Baseline 1); Week 1 (Baseline 2); Week 10 (Follow-Up)

  • Change in Patient Specific Functional Scale

    Week 0 (Baseline 1); Week 10 (Follow-Up)

Study Arms (1)

Strength training

EXPERIMENTAL

Strength exercises for ankle PF, hip abduction, and trunk muscles. Exercises will be done in three standard positions of supine, sidelying, prone, seated, and standing. Exercises during the initial 4 weeks will be completed 2x week with supervision of a physical therapist and 2x week at home, for a total of 4x week. For the final 4 weeks of the intervention will be completed 1x week with supervision and 3x week at home.

Other: Strength exercise

Interventions

Strengthening exercises performed with physical therapist.

Strength training

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • People with MS,
  • Age 18-65,
  • A confirmed diagnosis of MS, and
  • Are ambulatory for 100m without an assistive device (EDDS 0-5.5), and
  • Have a gait speed measured by time to walk the 25-foot walk test of at least five seconds.

You may not qualify if:

  • Subjects are not ambulatory,
  • Subjects rely on a wheelchair,
  • Subjects cannot ambulate 100m (EDDS 6 or greater) without use of assistive devices, braces, or orthotics,
  • Walk the T25FW in less than five seconds,
  • Have lower extremity spasticity of 2 or greater on the Modified Ashworth Scale (MAS),
  • Have pain or other conditions that limit ambulation or ability to test muscle strength,
  • Cannot give consent,
  • Cannot follow simple directions,
  • Have had an exacerbation in the past month,
  • Have had changes to their drug therapy in the last month,
  • Have other neurologic diagnoses, or
  • Are currently undergoing physical therapy for strength training.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Denver

Aurora, Colorado, 80045, United States

Location

Related Publications (1)

  • Manago MM, Hebert JR, Schenkman M. Psychometric Properties of a Clinical Strength Assessment Protocol in People with Multiple Sclerosis. Int J MS Care. 2017 Sep-Oct;19(5):253-262. doi: 10.7224/1537-2073.2016-078.

    PMID: 29070966BACKGROUND

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Margaret Schenkman, PT, PhD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2017

First Posted

June 5, 2017

Study Start

May 23, 2017

Primary Completion

November 8, 2017

Study Completion

November 8, 2017

Last Updated

April 13, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations